Kimberly-Clark Set To Spin-Off Medical Biz With Device, Infection-Prevention Focus
This article was originally published in The Gray Sheet
The new company, set to launch on Nov. 1 as Halyard Health, will focus on products intended to stop hospital acquired infections as well as pain, respiratory, and digestive health devices.
You may also be interested in...
Stryker will pay nearly $2.8 billion to buy Sage Products and its portfolio of products to prevent health care "never events," which hospitals are increasingly motivated to avoid.
The parts of Kimberly-Clark that are now Halyard had about $1.7 billion in sales of surgical and infection prevention products and other medical devices in 2013.
The market for diagnostic and infection control products will see continued growth as hospitals and other providers look to the technology sector to help fight the battle against health care-associated infections and antibiotic-resistant organisms.